Pan-European Operations for Specialty Care
Situation | Offering Benefits
- Doing business in Europe is becoming more complex and less profitable: Budget constraints, tighter price controls, the emergence of new players (e.g. NICE, IQWiG) who influence the reimbursement process, and the increasing difficulty to access and build trusting relationships with healthcare professionals in a period of increasingly empowered patients creates a dynamic and challenging environment.
- The old share of voice model is showing limitations and organizations realize that they need to evolve and innovate to succeed in this environment. They therefore embark on transforming their European organizations.
- In the converging European pharmaceutical business new opportunities arise specifically while looking at new ways to serve niche customer groups or promote highly specialized products through centralized and integrated organizations at European level.
- For the past 5 years Executive Insight has been helping healthcare organisations develop, define and implement Pan-European go-to-market models for their specialty units.
- We have a proven track record in the areas of Cardiology, Intensive care, Oncology, Nephrology, Dermatology, Rheumatology and Gastro-Enterology.
- We have developed deep expertise and unique skills to accurately and quickly allow you to identify new business models to increase the profitability of your European commercial operations.
- Efficient sales force allocation through optimized coverage (up to 20% less headcounts)
- Improved targeting accuracy (23% new customers served)
- Optimal leverage of dedicated and scaleable resource across country borders (up to 40% less headcounts in the support organization, dedicated resources also for medium/small-sized coutries)
- Optimal coverage of cross-border decision-making and influence networks
- Critical mass to provide a wider range of value-added services (e.g. 24/7 customer services)
- Best-in-class customer equity generated after 2 years from launch